| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
REVIEW
Pathologic differential diagnosis of metastatic carcinoma in the liver
The liver is one of the most common sites to which malignancies preferentially metastasize. Although a substantial number of liver malignancies are primary tumors, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma, the metastasis of carcinomas to the liver i...
REVIEW
Radiomics and radiogenomics of primary liver cancers
Concurrent advancements in imaging and genomic biomarkers have created opportunities to identify non-invasive imaging surrogates of molecular phenotypes. In order to develop such imaging surrogates radiomics and radiogenomics/imaging genomics will be necessary; there has been co...
ORIGINAL ARTICLE
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Background/Aims: An estimated 80 million people worldwide are infected with viremic hepatitis C virus (HCV). Even after eradication of HCV with direct acting antivirals (DAAs), hepatic fibrosis remains a risk factor for hepatocarcinogenesis. Recently, we confirmed the applicabil...
ORIGINAL ARTICLE
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) is becoming a worldwide epidemic, and is frequently found in patients with chronic hepatitis B (CHB). We investigated the impact of histologically proven hepatic steatosis on the risk for hepatocellular carcinoma (HCC) in...
Current Issue
Volume 25(1); Mar 2019
Volume 24(4); December 2018
Volume 24(3); September 2018
Volume 24(2); June 2018
Volume 24(1); March 2018
RSS feed
Most-cited are based on citations from 2017 ~ 2019.
Genetic predisposition in nonalcoholic fatty liver disease
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol.2017;23(1):1-12.   Published online March 9, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0109
                                 Cited By 40
Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis
Gaeun Kim, Moon Young Kim, Soon Koo Baik
Clin Mol Hepatol.2017;23(1):34-41.   Published online March 7, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0059
                                 Cited By 18
Current status and strategies for hepatitis B control in Korea
Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim
Clin Mol Hepatol.2017;23(3):205-211.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0104
                                 Cited By 13
Anticoagulation in cirrhosis: a new paradigm?
Filippo Leonardi, Nicola De Maria, Erica Villa
Clin Mol Hepatol.2017;23(1):13-21.   Published online March 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0110
                                 Cited By 12
Microbiota, a key player in alcoholic liver disease
Anne-Marie Cassard, Dragos Ciocan
Clin Mol Hepatol.2018;24(2):100-107.   Published online December 22, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0067
                                 Cited By 11
Radioembolization for the treatment of hepatocellular carcinoma
Hyo-Cheol Kim
Clin Mol Hepatol.2017;23(2):109-114.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0004
                                 Cited By 10
Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin
Clin Mol Hepatol.2017;23(4):280-289.   Published online September 15, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0037
                                 Cited By 10
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
Edward Wolfgang Lee, Sarah Khan
Clin Mol Hepatol.2017;23(4):265-272.   Published online November 8, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0111
                                 Cited By 10
Epidemiology of liver cancer in South Korea
Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol.2018;24(1):1-9.   Published online December 18, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0112
                                 Cited By 10
Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae
Clin Mol Hepatol.2017;23(1):51-56.   Published online March 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0053
                                 Cited By 9
Histopathological evaluation of liver fibrosis and cirrhosis regression
Regina C. Lo, Haeryoung Kim
Clin Mol Hepatol.2017;23(4):302-307.   Published online December 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0078
                                 Cited By 9
Epithelioid angiomyolipoma of the liver: a case report
Soo Yeon Lee, Baek-hui Kim
Clin Mol Hepatol.2017;23(1):91-94.   Published online March 17, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0011
                                 Cited By 8
NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Stephen Caldwell
Clin Mol Hepatol.2017;23(2):103-108.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0103
                                 Cited By 8
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol.2017;23(2):128-137.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0071
                              Supplementary         Cited By 8
Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique
Clin Mol Hepatol.2017;23(4):316-322.   Published online August 22, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0087
                                 Cited By 8
Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
Dong Ho Lee
Clin Mol Hepatol.2017;23(4):290-301.   Published online October 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0042
                                 Cited By 8
The use of immunosuppression in autoimmune hepatitis: A current literature review
Angela Cropley, Martin Weltman
Clin Mol Hepatol.2017;23(1):22-26.   Published online March 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0089
                                 Cited By 6
Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
Tae Wook Kang, Hyo Keun Lim, Dong Ik Cha
Clin Mol Hepatol.2017;23(1):95-101.   Published online March 24, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0006
                                 Cited By 6
Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Imane El Dika, Ghassan K. Abou-Alfa
Clin Mol Hepatol.2017;23(4):273-279.   Published online November 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0108
                                 Cited By 6
Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
Goh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, Jeong-ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim
Clin Mol Hepatol.2017;23(1):66-73.   Published online February 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0060
                                 Cited By 5
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 214
TOTAL : 130485